Efficacy and Safety of the Selective alpha1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea

Ki-Hak MOON; Phil-Hyun SONG; Dae-Yul YANG; Nam-Cheol PARK; Soo-Woong KIM; Sung-Won LEE; Sae-Woong KIM; Du-Geon MOON; Jong-Kwan PARK; Tai-Young AHN; Kwangsung PARK.
Korean Journal of Urology ; : 335-340, 2014.
Artículo en Inglés | WPRIM | ID: wpr-17194

Documentos relacionados

  1. Comparison of IPSS score and voiding parameters in men presenting with LUTS.
  2. Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.
  3. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
  4. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
  5. Prevalence and Distribution of Postvoid Residual Urine Volume in a Hospital-Based Sample of Men with Symptomatic Benign Prostatic Hyperplasia.
  6. Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement?
  7. Effect of Prostate Artery Embolization on Erectile Function - A Single Center Experience of 167 Patients.
  8. [Evaluation of the effect of Alfuprost MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia].
  9. Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.
  10. [Benign Prostate Hyperplasia - Current Medical Therapy, New Developments, and Side Effects].